Dr. Wang Yi from School of Economics and Management of Tsinghua University Joins Great Bay Bio as Strategic Consultant

Created on:2020-02-11 14:43

logo                                                           

                                                            February 10th,2020 Press Release

Dr. Wang Yi from School of Economics and Management of Tsinghua University Joins Great Bay Bio as Strategic Consultant

 

[2020/2/10, Dongguan] Recently, Dr. Wang Yi (Associate Professor) from Tsinghua University joins the 3D consultation committee of Great Bay Bio. Dr. Michael Chen, the CEO of Great Bay Bio, said that having Dr. Wang in the consultation committee would great promote our biologics development, commercialization of AI Bio platform, and strategic planning. 

 

Dr. Wang is the Associate Professor of Department of Innovation, Entrepreneurship and Strategy of Tsinghua SEM, doctoral tutor, Deputy Director of Research Center for Technological Innovation of Tsinghua University, the Director of Chinese Society of Technology Economics, the Deputy Director and Deputy Secretary General of the Incubation & Innovation Environment Sub-committee of Chinese Society of Technology Economics, the Deputy Secretary General of Enterprise Technology Innovation Committee in the China Enterprise Confederation, the Committee Member of the National Enterprise Management Modernization & Innovation Review Committee.

img3

In 1996, he studied for Ph.D. under the supervision of academician Xu Qingrui in Zhejiang University. Later, he became a visiting scholar of Stanford Graduate School of Business (2005) and MIT Alfred P. Sloan School of Management (2012). His visiting to MIT Alfred P. Sloan School of Management (2013-2014) was funded by Fulbright Senior Visiting Scholar Project of the U.S. government. Dr. Wang’s researches cover management of enterprise technological innovation, which is highly recognized by his peers. He is a highly cited editor in CNKI and was listed as one of the 32 most productive authors of “Studies on Management in China” from 2001 to 2011. He has published many books and textbooks, including Management of Technological Innovation (Third Edition), Innovation Capabilities of China’s Leading Companies, and Corporate Core Capabilities and Technological Innovation Strategy. He has taught Ph.D., MBA and bachelor students such courses as Management of Technological Innovation, Innovation Management, Innovation and Change, Entrepreneurial Management, Business Plan, Decision-making of Project Investment and Finance, Engineering Economics, and Organization, Environment and Competitive Advantage. He also provides consultation on technology innovation management for huge enterprises like CRRC, CASC, AVIC and Midea.

 

About Great Bay Bio

Headquartered in Hong Kong, GBB is a high-tech enterprise dedicated to applying artificial intelligence and other cutting-edge technologies to CMC (Chemistry, Manufacturing, Control) for development of biopharmaceuticals and other blue ocean bio-products (such as cell therapy), ultimately solving numerous pain points of CMC development, including high failure rates, long development timeline and high costs. Since the company’s establishment, it has obtained massive data from conventional biologics development in its 3100 m2 CMC facilities in Dongguan, PRC. With over RMB 300M investment, the facilities bolster advance equipment from world-renowned manufacturers. GBB has also successfully brought a number of biologic products to NDA stage, some of which are classified as national class I innovative drugs. Currently, the company has created the intelligent centralized database, where deep learning is being performed to create next generation AI-enabled CMC platforms. To learn more, please visit http://www.greatbay-bio.com.

 

PR Contact: Miss Liu 

Email: yt.liu@greatbay-bio.com

Home    News    Dr. Wang Yi from School of Economics and Management of Tsinghua University Joins Great Bay Bio as Strategic Consultant
PV:0
Collect